vs
Amalgamated Financial Corp.（AMAL）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
Amalgamated Financial Corp.的季度营收约是STEM, INC.的1.8倍（$85.2M vs $47.1M），Amalgamated Financial Corp.同比增速更快（9.4% vs -15.6%），过去两年STEM, INC.的营收复合增速更高（36.1% vs 4.3%）
CI金融集团是一家总部位于加拿大安大略省多伦多的投资管理公司，面向高净值个人投资者提供投资管理与财富管理服务，同时也为投资组合经理及机构投资者提供经纪与交易服务。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
AMAL vs STEM — 直观对比
营收规模更大
AMAL
是对方的1.8倍
$47.1M
营收增速更快
AMAL
高出24.9%
-15.6%
两年增速更快
STEM
近两年复合增速
4.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $85.2M | $47.1M |
| 净利润 | — | $-16.0M |
| 毛利率 | — | 48.9% |
| 营业利润率 | 39.0% | -17.7% |
| 净利率 | — | -33.9% |
| 营收同比 | 9.4% | -15.6% |
| 净利润同比 | — | 68.8% |
| 每股收益（稀释后） | $0.88 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMALSTEM
| Q4 25 | $85.2M | $47.1M | ||
| Q3 25 | $85.6M | $38.2M | ||
| Q2 25 | $80.9M | $38.4M | ||
| Q1 25 | $77.0M | $32.5M | ||
| Q4 24 | $77.9M | $55.8M | ||
| Q3 24 | $81.0M | $29.3M | ||
| Q2 24 | $78.5M | $34.0M | ||
| Q1 24 | $78.3M | $25.5M |
净利润AMALSTEM
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $26.8M | $-23.8M | ||
| Q2 25 | $26.0M | $202.5M | ||
| Q1 25 | $25.0M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $27.9M | $-148.3M | ||
| Q2 24 | $26.8M | $-582.3M | ||
| Q1 24 | $27.2M | $-72.3M |
毛利率AMALSTEM
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
营业利润率AMALSTEM
| Q4 25 | 39.0% | -17.7% | ||
| Q3 25 | 42.9% | -33.6% | ||
| Q2 25 | 43.8% | -34.8% | ||
| Q1 25 | 45.1% | -65.0% | ||
| Q4 24 | 42.4% | -84.4% | ||
| Q3 24 | 47.2% | -493.2% | ||
| Q2 24 | 45.6% | -1705.5% | ||
| Q1 24 | 49.2% | -267.0% |
净利率AMALSTEM
| Q4 25 | — | -33.9% | ||
| Q3 25 | 31.3% | -62.2% | ||
| Q2 25 | 32.1% | 527.8% | ||
| Q1 25 | 32.5% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | 34.5% | -506.3% | ||
| Q2 24 | 34.1% | -1712.6% | ||
| Q1 24 | 34.8% | -283.9% |
每股收益（稀释后）AMALSTEM
| Q4 25 | $0.88 | $-4.40 | ||
| Q3 25 | $0.88 | $-2.84 | ||
| Q2 25 | $0.84 | $-1.79 | ||
| Q1 25 | $0.81 | $-0.15 | ||
| Q4 24 | $0.78 | $-15.29 | ||
| Q3 24 | $0.90 | $-18.24 | ||
| Q2 24 | $0.87 | $-71.81 | ||
| Q1 24 | $0.89 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $291.2M | $48.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $794.5M | $-249.4M |
| 总资产 | $8.9B | $308.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMALSTEM
| Q4 25 | $291.2M | $48.9M | ||
| Q3 25 | $115.5M | $43.1M | ||
| Q2 25 | $171.1M | $40.8M | ||
| Q1 25 | $65.7M | $58.6M | ||
| Q4 24 | $60.7M | $56.3M | ||
| Q3 24 | $149.2M | $75.4M | ||
| Q2 24 | $58.0M | $89.6M | ||
| Q1 24 | $155.2M | $112.8M |
股东权益AMALSTEM
| Q4 25 | $794.5M | $-249.4M | ||
| Q3 25 | $775.6M | $-235.7M | ||
| Q2 25 | $754.0M | $-214.1M | ||
| Q1 25 | $736.0M | $-417.5M | ||
| Q4 24 | $707.7M | $-398.4M | ||
| Q3 24 | $698.2M | $-344.1M | ||
| Q2 24 | $646.0M | $-203.2M | ||
| Q1 24 | $616.8M | $371.6M |
总资产AMALSTEM
| Q4 25 | $8.9B | $308.9M | ||
| Q3 25 | $8.7B | $362.6M | ||
| Q2 25 | $8.6B | $379.2M | ||
| Q1 25 | $8.3B | $405.1M | ||
| Q4 24 | $8.3B | $437.4M | ||
| Q3 24 | $8.4B | $537.8M | ||
| Q2 24 | $8.3B | $691.5M | ||
| Q1 24 | $8.1B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $135.8M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $134.4M | — |
| 自由现金流率自由现金流/营收 | 157.8% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $229.4M | — |
8季度趋势，按日历期对齐
经营现金流AMALSTEM
| Q4 25 | $135.8M | $8.2M | ||
| Q3 25 | $39.5M | $11.4M | ||
| Q2 25 | $24.9M | $-21.3M | ||
| Q1 25 | $34.2M | $8.5M | ||
| Q4 24 | $124.1M | $-14.7M | ||
| Q3 24 | $35.8M | $-9.4M | ||
| Q2 24 | $28.0M | $-11.9M | ||
| Q1 24 | $31.3M | $-621.0K |
自由现金流AMALSTEM
| Q4 25 | $134.4M | — | ||
| Q3 25 | $38.3M | — | ||
| Q2 25 | $24.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | $122.3M | — | ||
| Q3 24 | $35.2M | — | ||
| Q2 24 | $27.8M | — | ||
| Q1 24 | $31.1M | — |
自由现金流率AMALSTEM
| Q4 25 | 157.8% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 29.9% | — | ||
| Q1 25 | 42.2% | — | ||
| Q4 24 | 157.0% | — | ||
| Q3 24 | 43.4% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 39.7% | — |
资本支出强度AMALSTEM
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
现金转化率AMALSTEM
| Q4 25 | — | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.96× | -0.11× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.28× | — | ||
| Q2 24 | 1.05× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
